Phibro Animal Health (PAHC) EPS (Weighted Average and Diluted) (2013 - 2026)

Phibro Animal Health's EPS (Weighted Average and Diluted) history runs 14 years deep, the most recent figure standing at $0.59 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 15.69% year-over-year to $0.59; the TTM figure through Mar 2026 stood at $2.34 (up 200.0% YoY), while the FY2025 annual figure was $1.19, up 1883.33% from the prior year.
• EPS (Weighted Average and Diluted) was $0.59 for Q1 2026 at Phibro Animal Health, down from $0.67 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.67 in Q4 2025 to a low of -$0.2 in Q3 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.27 across 5 years, with a median of $0.21 in 2024.
• The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) sank 300.0% in 2023, then soared 2050.0% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.18 in 2022, then sank by 83.33% to $0.03 in 2023, then soared by 166.67% to $0.08 in 2024, then jumped by 737.5% to $0.67 in 2025, then decreased by 11.94% to $0.59 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.59 (Q1 2026), $0.67 (Q4 2025), and $0.65 (Q3 2025), per Business Quant data.